Executive Function Deficits in Patients with Blepharospasm


Authors: T. Nikolai 1;  O. Bezdíček 1;  P. Kleinová 1;  M. Šmíra 2;  E. Růžička 1;  J. Roth 1
Authors‘ workplace: Neurologická klinika a Centrum klinických neurověd, 1. LF UK a VFN v Praze 1;  Katedra psychologie, FSS MU, Brno 2
Published in: Cesk Slov Neurol N 2016; 79/112(6): 687-691
Category: Original Paper

Overview

Aim:
The aim of our study was to identify selective cognitive abnormalities in cognitive performance of essential blepharospasm (EB) patients. Introduction: EB and other types of focal dystonia have long been considered as a purely motor disorder. In recent years, there has been mounting evidence for non-motor abnormalities due to basal ganglia dysfunction in patents with EB, including selective cognitive deficits.

Material and methods:
We recruited 20 patients with EB, 20 patients with hemifacial spasm (HFS) and 23 demographically matched controls (NC). All participants (EB + HFS + NC) underwent brief neuropsychological battery focused on executive functioning. Furthermore, the patients (EB + HFS) were matched according to their disease duration, treatment duration. Patients were assessed near the peak of botulinum toxin treatment effect.

Results:
EB patients had significantly longer times (more impaired performance) in the Prague Stroop Test weak interference condition (naming neutral words) in comparison to patients with HFS (W = 301.5; p = 0.006) and HC (W = 362; p < 0.001). EB patients also had higher level of anxiety symptoms than NC as measured by STAI (STAI X1: W = 377; p < 0.001; STAI X2: W = 408; p < 0.001).

Conclusion:
We found mild executive dysfunction in patients with EB manifesting as higher sensitivity to interference. Unlike other studies, we compared our results with HFS patients that were similar in basic clinical and demographic characteristics and underwent the same botulinum toxin treatment as the EB group. Furthermore, we found higher level of trait and state anxiety in EB patients compared to NC (but not HFS).

Key words:
blepharospasm – executive functions – hemispasm – neuropsychology

Autoři deklarují, že v souvislosti s předmětem studie nemají žádné komerční zájmy.

Redakční rada potvrzuje, že rukopis práce splnil ICMJE kritéria pro publikace zasílané do biomedicínských časopisů.


Sources

1. Defazio G, Berardel­li A, Hal­lett M. Do primary adult-onset focal dystonias share aetiological factors? Brain 2007;130(5):1183– 93.

2. Jin­nah HA, Berardel­li A, Comel­la C, et al. The focal dystonias: cur­rent views and chal­lenges for future research. Mov Disord 2013;28(7):926– 43. doi: 10.1002/ mds.25567.

3. Defazio G, Livrea P. Epidemiology of primary blepharospasm. Mov Disord 2002;17(1):7– 12.

4. Rosenstengel C, Matthes M, Baldauf J, et al. Hemifacial spasm: conservative and surgical treatment options. Dtsch Arztebl Int 2012;109(41):667– 73. doi: 10.3238/ arztebl.2012.0667

5. Leisman G, Melil­lo R. The basal ganglia: motor and cognitive relationships in a clinical neurobehavioral context. Rev Neurosci 2013;24(1):9– 25. doi: 10.1515/ revneuro-2012-0067.

6. R­ing HA, Ser­ra-Mestres J. Neuropsychiatry of the basal ganglia. J Neurol Neurosurg Psychiatry 2002;72(1):12– 21.

7. Laricchiuta D, Petrosini L, Piras F, et al. Link­ing novelty seek­ing and harm avoidance personality traits to basal ganglia: volumetry and mean dif­fusivity. Brain Struct Funct 2014;219(3):793– 803. doi: 10.1007/ s00429-013-0535-5.

8. Ron MA. Primary focal dystonia –  a disease of brain and mind: motor and psychiatric manifestations have a com­mon neurobio­logical basis. J Neurol Neurosurg Psychiatry. 2009;80(10):1059. doi: 10.1136/ jn­np.2009.174508.

9. Jahanshahi M, Rowe J, Ful­ler R. Cognitive executive function in dystonia. Mov Disord 2003;18(12):1470– 81.

10. Scott RB, Gregory R, Wilson J, et al. Executive cognitive deficits in primary dystonia. Mov Disord 2003;18(5):539– 50.

11. Dias FM, Doyle FC, Kum­mer A, et al. Executive function­ing in patients with blepharospasm in comparison with patients with hemifacial spasm. Arq Neuropsiquiatr 2009;67(1):12– 5.

12. Alemán GG, De Erausquin G, Micheli F. Cognitive disturbances in primary blepharospasm. Mov Disord 2009;24(14):2112– 20. doi: 10.1002/ mds.22736.

13. Štěpánková H, Nikolai T, Lukavský J et al. Mini-Mental State Examination –  česká normativní studie. Cesk Slov Neurol N 2015;78/ 111(1):57– 63.

14. Nikolai T, Štěpánková H, Michalec J et al. Testy verbální fluence, česká normativní studie pro osoby vyššího věku. Cesk Slov Neurol N 2015;78/ 111(3):292– 9.

15. Bezdicek O, Lukavsky J, Stepankova H, et al. The Prague Stroop Test: normative standards in older Czech adults and discriminative validity for mild cognitive impairment in Parkinson’s disease. J Clin Exp Neuropsychol 2015;37(8):794– 807. doi: 10.1080/ 13803395.2015.1057106.

16. Dubois B, Slachevsky A, Litvan I, et al. The FAB: a frontal as­ses­sment battery at bedside. Neurology 2000;55(11):1621– 6.

17. Spielberger CD, Gorsuch RL, Lushere RE et al. State-Trait Anxiety Inventory. Prof Psychol 1971;3(4):389– 90.

18. Beck AT, Steer RA, Brown GK. Beck depres­sion inventory II. San Antonio TX: Harcourt Brace 1996.

19. Albanese A, Del Sorbo F, Comel­la C, et al. Dystonia rat­ing scales: critique and recom­mendations. Mov Disord 2013;28(7):874– 83. doi: 10.1002/ mds.25579.

20. Benjamini Y, Hochberg Y. Control­l­ing the false discovery rate –  a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodological 1995;57(1):289– 300.

21. Lars­son MU, Almkvist O, Luszcz MA, et al. Phonemic fluency deficits in asymp­tomatic gene car­riers for Huntington’s disease. Neuropsychology 2008;22(5):596– 605. doi: 10.1037/ 0894-4105.22.5.596.

22. Troyer AK, Leach L, Strauss E. Ag­ing and response inhibition: normative data for the Victoria Stroop Test. Neuropsychol Dev Cogn B Ag­ing Neuropsychol Cogn 2006;13(1):20– 35.

23. Krivá L. Stroopův test. Praha: Hogrefe Testcentrum 2013.

24. Litvan I, Goldman JG, Tröster AI, et al. Dia­gnostic criteria for mild cognitive impairment in Parkinson’s dis­ease: movement disorder society task force guidelines. Mov Disord 2012;27(3):349– 56. doi: 10.1002/ mds.24893.

25. Peinemann A, Schul­ler S, Pohl C, et al. Executive dysfunction in early stages of Huntington’s disease is as­sociated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. J Neurol Sci 2005;239:11– 9.

26. Barahona-Cor­rêa B, Bugalho P, Guimarães J, et al. Obses­sive-compulsive symp­toms in primary focal dystonia: a control­led study. Mov Disord 2011;26(12):2274– 8. doi: 10.1002/ mds.23906.

27. Fabbrini G, Berardel­li I, Moretti G, et al. Psychiatric disorders in adult-onset focal dystonia: a case-control study. Mov Disord 2010;25(4):459– 65. doi: 10.1002/ mds.22983.

28. Fontenel­le LF, Pacheco PG, Nascimento PM, et al. Obses­sive-compulsive symp­toms among patients with blepharospasm and hemifacial spasm. Gen Hosp Psychiatry 2011;33(5):476– 81. doi: 10.1016/ j.genhosppsych.2011.05.016.

29. Grandas F, Elston J, Quinn N, et al. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 1988;51(6):767– 72.

30. Wenzel T, Schnider P, Griengl H, et al. Psychiatric disorders in patients with blepharospasm –  a reactive pattern? J Psychosom Res 2000;48(6):589– 91.

Labels
Paediatric neurology Neurosurgery Neurology

Article was published in

Czech and Slovak Neurology and Neurosurgery

Issue 6

2016 Issue 6

Most read in this issue
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account